Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Alert
Watchlist
Venmax Drugs & Pharmaceuticals
₹29.99
+1.00 (3.45%) 1D
Performance
Open
28.99Prev. Close
28.99Volume
55Total traded value
0.00 CrUpper Circuit
30.43Lower Circuit
27.55Fundamentals
| Market Cap | ₹15Cr |
| ROE | 4.02% |
| P/E Ratio(TTM) | 43.92 |
| EPS(TTM) | 0.66 |
| P/B Ratio | 2.61 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.46 |
| Book Value | 11.09 |
| Debt to Equity | 0.36 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Venmax Drugs
Venmax Drugs & Pharmaceuticals is in the business of making pharmaceutical products, drug intermediaries, and Active Pharmaceutical Ingredients (APIs). The company's management is looking into alternative business proposals to resume operations in the future. In the last financial year, the company incurred a loss of Rs. 6.45 Lakhs due to the absence of business activity.;
| Parent Organisation | Venmax Drugs & Pharmaceuticals Limited |
| BSE Symbol | 531015 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 69.56 | ||
| Neuland Laboratories | NA (0.00%) | 93.26 | ||
| Jubilant Pharmova | NA (0.00%) | 37.91 | ||
| Acutaas Chemicals | NA (0.00%) | 62.11 |